Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Access Bio Inc

Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, a... read more Featured Products: More products

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Malaria Rapid Test Evaluated in Low Transmission Area

By LabMedica International staff writers
Posted on 23 Aug 2017
Light microscopy detecting human malarial parasites in Giemsa-stained thick and thin blood films still remains the gold standard for malaria diagnosis. More...
In many peripheral health centers of endemic countries, microscopy is not available due to limited resources or lack of expertise.

Malaria rapid diagnostic tests (RDTs), based on immunochromatographic parasite antigen detection, are of great value in endemic regions. However, it remains unclear whether RDTs are useful in field conditions in low transmission areas since their reliability is limited by the lack of detection of low-density parasitemia.

Scientists at Cheikh Anta Diop University (Dakar, Senegal) enrolled 215 patients suspected of malaria in two peri-urban area of Dakar. Blood samples were collected for RDT and microscopy, and a filter paper collected for polymerase chain reaction (PCR). Inclusion criterion for this study was individuals with fever and suspicion of malaria and without clinical sign of severe malaria.

The team made both thick and thin films were made in the same slide which were stained and examined. Finger prick blood sample were tested for malaria parasites using CareStart Malaria HRP2/pLDH Combo Test in the field. CareStart RDT is an immunochromatographic test coated with monoclonal antibodies in two separate bands, one recognizing the specific histidine-rich protein-2 (HRP-2) associated with the presence of Plasmodium falciparum and the other detecting presence of pan malaria-specific antigen (pLDH) of all malarial parasites species. The real-time PCR assay, known as photo-induced electron transfer (PET)-PCR, was also performed.

The investigators reported that when considering PCR as the gold standard, CareStart RDT showed high sensitivity (97.3%) and specificity (94.1%) with a positive predictive value (PPV) and negative predictive value (NPV) of 97.3% and 94.1%, respectively. Microscopy had a sensitivity of 93.2% and specificity of 100%, and PPV and NPV of 100% and 87.2%, respectively. CareStart RDT showed less false negative but more false positive results compared to microscopy.

The authors concluded that although RDT usefulness in low transmission areas or in the detection of low parasite density infections is being questioned, CareStart RDT showed good sensitivity comparable to that performed by expert microscopist. However, in the wake of reported HRP2 deletion in other countries, microscopy should always accompany the use of RDT. Combination of RDT and microscopy together with the evaluation of malaria RDTs over time should be a powerful tool for diagnosing malaria in endemic countries. The study was published on August 10, 2017, in the Malaria Journal.

Related Links:
Cheikh Anta Diop University


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.